Amphastar Pharmaceuticals (29A.F) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
0.61
0.71
0.8
0.9

Details

Expected EPS
0.71456678965
Actual EPS
0.8051847
Surprise EPS
0.09
Surprise Percent
+12.68%

Description

Amphastar Pharmaceuticals (29A.F) has reported earnings of 0.8051847 per share for Q4 2025.

0 Comments

Share your thoughts